The DOI matches its Crossref record; 1,155 of the 1,155 references it cites were found in a registry or an index.
Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Abstract
Neurodegenerative diseases pose a substantial socioeconomic burden on society. Unfortunately, the aging world population and lack of effective cures foreshadow a negative outlook. Although a large amount of research has been dedicated to elucidating the pathologies of neurodegenerative diseases, their principal causes remain elusive. Metal ion dyshomeostasis, proteopathy, oxidative stress, and neurotransmitter deficiencies are pathological features shared across multiple neurodegenerative disorders. In addition, these factors are proposed to be interrelated upon disease progression. Thus, the development of multifunctional compounds capable of simultaneously interacting with several pathological components has been suggested as a solution to undertake the complex pathologies of neurodegenerative diseases. In this review, we outline and discuss possible therapeutic targets in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis and molecules, previously designed or discovered as potential drug candidates for these disorders with emphasis on multifunctionality. In addition, underrepresented areas of research are discussed to indicate new directions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 601–800 of 1,155
Kovacs, G. G., Wagner, U., Dumont, B., Pikkarainen, M., Osman, A. A., Streichenberger, N., Leisser, I., Verchère, J., Baron, T., Alafuzoff, I., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0964-x · Cited by 169
NMR Reveals Anomalous Copper(II) Binding to the Amyloid Aβ Peptide of Alzheimer's Disease
Hou, L., & Zagorski, M. G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja046032u · Cited by 169
Landreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Takeuchi, H., Kobayashi, Y., Ishigaki, S., Doyu, M., & Sobue, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209356200 · Cited by 169
Matos, M. J., Terán, C., Pérez-Castillo, Y., Uriarte, E., Santana, L., & Viña, D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200716y · Cited by 169
Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168
18 F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
Smith, R., Puschmann, A., Schöll, M., Ohlsson, T., van Swieten, J., Honer, M., Englund, E., & Hansson, O. (2016) · Brain · doi:10.1093/brain/aww163 · Cited by 168
BROWN, M., Evans, J. L., & LUO, Y. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.10.017 · Cited by 168
Syme, C. D., & Viles, J. H. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.09.012 · Cited by 167
Hirohata, M., Hasegawa, K., Tsutsumi-Yasuhara, S., Ohhashi, Y., Ookoshi, T., Ono, K., Yamada, M., & Naiki, H. (2007) · Biochemistry · doi:10.1021/bi061540x · Cited by 167
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 167
Carboni, E., & Lingor, P. (2015) · Metallomics · doi:10.1039/c4mt00339j · Cited by 166
Drew, S. C., Masters, C. L., & Barnham, K. J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja903669a · Cited by 166
Iron transport proteins: Gateways of cellular and systemic iron homeostasis
Knutson, M. D. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.786632 · Cited by 165
Szegletes, T., Mallender, W. D., Thomas, P. J., & Rosenberry, T. L. (1999) · Biochemistry · doi:10.1021/bi9813577 · Cited by 164
Nagatsu, T., & Sawada, M. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_7 · Cited by 164
Rhodanine‐Based Tau Aggregation Inhibitors in Cell Models of Tauopathy
Bulic, B., Pickhardt, M., Khlistunova, I., Biernat, J., Mandelkow, E., Mandelkow�, E., & Waldmann, H. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200704051 · Cited by 164
Parkinson's disease mortality and the industrial use of heavy metals in Michigan
Rybicki, B. A., Johnson, C. C., Uman, J., & Gorell, J. M. (1993) · Movement Disorders · doi:10.1002/mds.870080116 · Cited by 163
Chen, H.-K., Liu, Z., Meyer-Franke, A., Brodbeck, J., Miranda, R. D., McGuire, J. G., Pleiss, M. A., Ji, Z.-S., Balestra, M. E., Walker, D. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276162 · Cited by 163
Two-electron electrochemical oxidation of quercetin and kaempferol changes only the flavonoid C-ring
Jørgensen, L. V., Cornett, C., Justesen, U., Skibsted, L. H., & Dragsted, L. O. (1998) · Free Radical Research · doi:10.1080/10715769800300381 · Cited by 163
Gentian Violet: a 19th century drug re‐emerges in the 21st century
Maley, A. M., & Arbiser, J. L. (2013) · Experimental Dermatology · doi:10.1111/exd.12257 · Cited by 163
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
Ma, T., Tan, M., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/350516 · Cited by 162
Selegiline for Alzheimer's disease
Birks, J., & Flicker, L. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000442 · Cited by 162
Zhong, S.-Z., Ge, Q.-H., Qu, R., Li, Q., & Ma, S.-P. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.10.008 · Cited by 161
The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice
Koh, S.-H., Lee, S. M., Kim, H. Y., Lee, K.-Y., Lee, Y. J., Kim, H.-T., Kim, J., Kim, M.-H., Hwang, M. S., Song, C., et al. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.056 · Cited by 161
A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo
Prabhudesai, S., Sinha, S., Attar, A., Kotagiri, A., Fitzmaurice, A. G., Lakshmanan, R., Ivanova, M. I., Loo, J. A., Klärner, F.-G., Schrader, T., et al. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0105-1 · Cited by 161
Soon, C. P. W., Donnelly, P. S., Turner, B. J., Hung, L. W., Crouch, P. J., Sherratt, N. A., Tan, J., Lim, N. K.-H., Lam, L. Q., Bica, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.274407 · Cited by 160
Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice
Lan, J., & Jiang, D. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 159
Gjerløff, T., Fedorova, T. D., Knudsen, K., Munk, O. L., Nahimi, A., Jacobsen, S., Danielsen, E. H., Terkelsen, A. J., Hansen, J., Pavese, N., et al. (2014) · Brain · doi:10.1093/brain/awu369 · Cited by 159
Metal Ion-dependent Effects of Clioquinol on the Fibril Growth of an Amyloid β Peptide
Raman, B., Ban, T., Yamaguchi, K.-I., Sakai, M., Kawai, T., Naiki, H., & Goto, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500309200 · Cited by 159
Xie, S.-S., Wang, X.-B., Li, J.-Y., Yang, L., & Kong, L.-Y. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.051 · Cited by 159
Tsunemi, T., & Krainc, D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt572 · Cited by 159
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Tatenhorst, L., Eckermann, K., Dambeck, V., Fonseca-Ornelas, L., Walle, H., Lopes da Fonseca, T., Koch, J. C., Becker, S., Tönges, L., Bähr, M., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0310-y · Cited by 158
Masoud, S. T., Vecchio, L. M., Bergeron, Y., Hossain, M. M., Nguyen, L. T., Bermejo, M. K., Kile, B., Sotnikova, T. D., Siesser, W. B., Gainetdinov, R. R., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.016 · Cited by 158
The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease
McCord, M. C., & Aizenman, E. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00077 · Cited by 158
Viayna, E., Sola, I., Bartolini, M., Simone, A. D., Tapia‐Rojas, C., Serrano, F. G., Sabaté, R., Juárez‐Jiménez, J., Pérez, B., Luque, F. J., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401824w · Cited by 158
Storr, T., Merkel, M., Song-Zhao, G. X., Scott, L. E., Green, D. E., Bowen, M. L., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068965r · Cited by 156
Oxidised derivatives of silybin and their antiradical and antioxidant activity
Gažák, R., Svobodová, A. R., Psotová, J., Sedmera, P., Přikrylová, V., Daniela Walterová, B., & Křen, V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.07.064 · Cited by 156
Nepovimová, E., Uliassi, E., Korábečný, J., Peña‐Altamira, E., Samez, S., Pesaresi, A., Garcia, G. E., Bartolini, M., Andrisano, V., Bergamini, C., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5010804 · Cited by 156
Bergman, J., & Lerner, V. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200203000-00009 · Cited by 156
Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155
Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS
Carrì, M. T., Valle, C., Bozzo, F., & Cozzolino, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00041 · Cited by 155
Huang, L., Lu, C., Sun, Y., Mao, F., Luo, Z., Su, T., Jiang, H., Shan, W., & Li, X. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300978h · Cited by 154
Akaishi, T., Morimoto, T., Shibao, M., Watanabe, S., Sakai‐Kato, K., Utsunomiya‐Tate, N., & Abe, K. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.052 · Cited by 154
Liu, Z., Yu, Y., Li, X., Ross, C. A., & Smith, W. W. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.01.004 · Cited by 154
Shamoto‐Nagai, M., Maruyama, W., Kato, Y., Isobe, K., Tanaka, M., Naoi, M., & Osawa, T. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10777 · Cited by 153
Geng, J., Li, M. C., Wu, L. J., Ren, J., & Qu, X. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003813 · Cited by 153
Neuroprotective Actions of Methylene Blue and Its Derivatives
Poteet, E. C., Winters, A., Yan, L., Shufelt, K., Green, K. N., Simpkins, J. W., Wen, Y., & Yang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048279 · Cited by 153
The TDP‐43 N‐terminal domain structure at high resolution
Mompeán, M., Romano, V. C., Pantoja‐Uceda, D., Stuani, C., Baralle, F. E., Buratti, E., & Laurents, D. V. (2016) · FEBS Journal · doi:10.1111/febs.13651 · Cited by 153
Xu, Z., Chen, S., Li, X., Luo, G., Li, L., & Le, W. (2006) · Neurochemical Research · doi:10.1007/s11064-006-9166-z · Cited by 152
Regitz, C., Fitzenberger, E., Mahn, F. L., Dußling, L. M., & Wenzel, U. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0894-1 · Cited by 152
Tóth, G., Gardai, S. J., Zago, W., Bertoncini, C. W., Cremades, N., Roy, S. L., Tambe, M. A., Rochet, J.-C., Galvagnion, C., Skibinski, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087133 · Cited by 151
Hertel, C., Terzi, E., Hauser, N., Jakob-Røtne, R., Seelig, J., & Kemp, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9412 · Cited by 151
Zheng, H., Youdim, M. B. H., & Fridkin, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900504c · Cited by 149
Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J., & Karlin, K. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803908 · Cited by 149
Savini, L., Gaeta, A., Fattorusso, C., Catalanotti, B., Campiani, G., Chiasserini, L., Pellerano, C., Novellino, E., McKissic, D., & Saxena, A. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255668 · Cited by 148
Binding of Zn(II), Cu(II), and Fe(II) ions to alzheimer's Aß peptide studied by fluorescence
Garzon-Rodriguez, W., Yatsimirsky, A. K., & Glabe, C. G. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00357-1 · Cited by 148
Chromone, a Privileged Scaffold for the Development of Monoamine Oxidase Inhibitors
Gaspar, A., Silva, T., Yáñez, M., Viña, D., Orallo, F., Ortuso, F., Uriarte, E., Alcaro, S., & Borges, F. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2004267 · Cited by 148
d ‐penicillamine reduces serum oxidative stress in Alzheimer’s disease patients
Squitti, R., Rossini, P. M., Cassetta, E., Moffa, F., Pasqualetti, P., Cortesi, M., Colloca, A., Rossi, L. C., & Finazzi‐Agrò, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00933.x · Cited by 145
Induction of Amyloid Fibrils by the C-Terminal Fragments of TDP-43 in Amyotrophic Lateral Sclerosis
Chen, A. K.-H., Lin, R. Y., Hsieh, E. Z.-J., Tu, P., Chen, R. P. ‐., Liao, T., Chen, W., Wang, C., & Huang, J. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9066207 · Cited by 145
Frydman‐Marom, A., Rechter, M., Shefler, I., Bram, Y., Shalev, D. E., & Gazit, E. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802123 · Cited by 145
Dopamine promotes formation and secretion of non-fibrillar alpha-synuclein oligomers
Lee, H.-J., Baek, S. M., Ho, D. H., Suk, J., Cho, E.-D., & Lee, S. (2011) · Experimental & Molecular Medicine · doi:10.3858/emm.2011.43.4.026 · Cited by 144
Self-citationOxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis?
Kabashi, E., Valdmanis, P. N., Dion, P. A., & Rouleau, G. A. (2007) · Annals of Neurology · doi:10.1002/ana.21319 · Cited by 144
Clementi, M. E., Marini, S., Coletta, M., Orsini, F., Giardina, B., & Misiti, F. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.041 · Cited by 144
An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
Carlomagno, Y., Chung, D.-E. C., Yue, M., Castanedes-Casey, M., Madden, B. J., Dunmore, J., Tong, J., DeTure, M., Dickson, D. W., Petrucelli, L., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794602 · Cited by 143
Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation
Crowe, A., James, M. J., Lee, V. M.-Y., Smith, A. B., Trojanowski, J. Q., Ballatore, C., & Brunden, K. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.436006 · Cited by 143
Peptide‐Based Inhibitors of Amyloid Assembly
Sciarretta, K. L., Gordon, D. J., & Meredith, S. C. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13015-3 · Cited by 143
Progress in Monoamine Oxidase (MAO) Research in Relation to Genetic Engineering
Nagatsu, T. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00085-8 · Cited by 143
Wang, L., Esteban, G., Ojima, M., Bautista‐Aguilera, Ó. M., Inokuchi, T., Moraleda, I., Iriepa, I., Samadi, A., Youdim, M. B. H., Romero, A., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.078 · Cited by 143
Newberg, A. B., Wintering, N., Plößl, K., Hochold, J., Stabin, M. G., Watson, M., Skovronsky, D., Clark, C. M., Kung, M., & Kung, H. F. (2006) · PubMed · Cited by 143
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141
Phosphodiesterases in neurodegenerative disorders
Bollen, E., & Prickaerts, J. (2012) · IUBMB Life · doi:10.1002/iub.1104 · Cited by 141
Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence
Popescu, B. F. G., George, M. J., Bergmann, U., Garachtchenko, A., Kelly, M., McCrea, R. P. E., Luening, K., Devon, R. M., George, G. N., Hanson, A. D., et al. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/3/012 · Cited by 141
Lublin, A. L., & Link, C. D. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.02.002 · Cited by 140
Zawisza, I. A., Rózga, M., & Bal, W. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.012 · Cited by 140
Dexter, D. T., Statton, S. A., Whitmore, C. L., Freinbichler, W., Weinberger, P., Tipton, K. F., Corte, L., Ward, R. J., & Crichton, R. R. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0531-3 · Cited by 139
Lelie, H., Liba, A., Bourassa, M. W., Chattopadhyay, M., Chan, P. K., Gralla, E. B., Miller, L. M., Borchelt, D., Valentine, J. S., & Whitelegge, J. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.186999 · Cited by 139
Giovanni, S. D., Eleuteri, S., Paleologou, K. E., Yin, G., Zweckstetter, M., Carrupt, P., & Lashuel, H. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.080390 · Cited by 139
Interaction of quercetin with copper ions: complexation, oxidation and reactivity towards radicals
Pękal, A., Biesaga, M., & Pyrzyńska, K. (2010) · BioMetals · doi:10.1007/s10534-010-9372-7 · Cited by 139
Bhatia, N. K., Srivastava, A., Malhotra, N., Jain, N., Khan, M. A. I., Kundu, B., & Deep, S. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.01.014 · Cited by 139
Schmidt, M. L., Martin, J. A., Lee, V. M. ‐., & Trojanowski, J. Q. (1996) · Acta Neuropathologica · doi:10.1007/s004010050454 · Cited by 138
Hureau, C., Balland, V., Coppel, Y., Solari, P. L., Fonda, E., & Faller, P. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0570-0 · Cited by 138
Zeevalk, G. D., & Nicklas, W. J. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08430.x · Cited by 138
Guilloreau, L., Damian, L., Coppel, Y., Mazarguil, H., Winterhalter, M., & Faller, P. (2006) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-006-0154-1 · Cited by 137
Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid β Toxicity
Rajasekhar, K., Madhu, C., & Govindaraju, T. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00175 · Cited by 137
Brain plasticity and ion channels
Debanne, D., Daoudal, G., Sourdet, V., & Russier, M. (2003) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2004.01.004 · Cited by 135
Bunina bodies in amyotrophic lateral sclerosis
Okamoto, K., Mizuno, Y., & Fujita, Y. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00873.x · Cited by 135
Durer, Z. A. O., Cohlberg, J. A., Dinh, P., Padua, S., Ehrenclou, K., Downes, S., Tan, J. K. Y., Nakano, Y., Bowman, C., Hoskins, J. L., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005004 · Cited by 134
Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model
Waibel, S., Reuter, A., Malessa, S., Blaugrund, E., & Ludolph, A. C. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0481-5 · Cited by 134
Baddeley, T. C., McCaffrey, J., Storey, J. M. D., Cheung, J. K. S., Melis, V., Horsley, D., Harrington, C. R., & Wischik, C. M. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219352 · Cited by 134
Cassagnes, L., Hervé, V., Nepveu, F., Hureau, C., Faller, P., & Collin, F. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305372 · Cited by 134
Bioinorganic chemistry of copper coordination to alpha-synuclein: Relevance to Parkinson's disease
Binolfi, A., Quintanar, L., Bertoncini, C. W., Griesinger, C., & Fernández, C. O. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.05.004 · Cited by 134
Wan, L., Nie, G., Zhang, J., Luo, Y., Zhang, P., Zhang, Z., & Zhao, B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.707 · Cited by 132
3D culture models of Alzheimer’s disease: a road map to a “cure-in-a-dish”
Choi, S. H., Kim, Y. H., Quinti, L., Tanzi, R. E., & Kim, D. Y. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0139-7 · Cited by 132
Cheignon, C., Jones, M., Atrián-Blasco, E., Kieffer, I., Faller, P., Collin, F., & Hureau, C. (2017) · Chemical Science · doi:10.1039/c7sc00809k · Cited by 132
Nonnative SOD1 trimer is toxic to motor neurons in a model of amyotrophic lateral sclerosis
Proctor, E. A., Fee, L., Tao, Y., Redler, R. L., Fay, J. M., Zhang, Y., Lv, Z., Mercer, I. P., Deshmukh, M., Lyubchenko, Y. L., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516725113 · Cited by 131
Effects of Various Flavonoids on the α -Synuclein Fibrillation Process
Meng, X., Munishkina, L. A., Fink, A. L., & Uversky, V. N. (2010) · Parkinson s Disease · doi:10.4061/2010/650794 · Cited by 131
The rotenone model of Parkinson's disease
Perier, C., Bové, J., Vila, M., & Przedborski, S. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00144-9 · Cited by 131
Pickhardt, M., Larbig, G., Khlistunova, I., Çoksezen, A., Meyer, B., Mandelkow, E., Schmidt, B., & Mandelkow�, E. (2007) · Biochemistry · doi:10.1021/bi700878g · Cited by 131
Danielson, S. R., Held, J. M., Schilling, B., Oo, M. L., Gibson, B. W., & Andersen, J. K. (2009) · Analytical Chemistry · doi:10.1021/ac901176t · Cited by 130
Biphasic and Region-Specific MAO-B Response to Aging in Normal Human Brain
Saura, J., Andrés, N., Andrade, C., Ojuel, J., Eriksson, K., & Mahy, N. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00113-9 · Cited by 130
Avramovich‐Tirosh, Y., Amit, T., Bar‐Am, O., Zheng, H., Fridkin, M., & Youdim, M. B. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04258.x · Cited by 130
Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants
Banci, L., Bertini, I., Boca, M., Calderone, V., Cantini, F., Girotto, S., & Vieru, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809845106 · Cited by 130
Asahina, M., Yoshiyama, Y., & Hattori, T. (2001) · PubMed · Cited by 129
Kupershmidt, L., Weinreb, O., Amit, T., Mandel, S. A., Carrì, M. T., & Youdim, M. B. H. (2009) · The FASEB Journal · doi:10.1096/fj.09-130047 · Cited by 129
Mao, X., & Schimmer, A. D. (2008) · Toxicology Letters · doi:10.1016/j.toxlet.2008.08.015 · Cited by 129
Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3
Koh, S., Noh, M., & Kim, S. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.064 · Cited by 129
Using C. elegans to discover therapeutic compounds for ageing-associated neurodegenerative diseases
Chen, X., Barclay, J. W., Burgoyne, R. D., & Morgan, A. (2015) · Chemistry Central Journal · doi:10.1186/s13065-015-0143-y · Cited by 129
Alpha‐synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells
Tehranian, R., Montoya, S. E., Laar, A. D. V., Hastings, T. G., & Perez, R. G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04146.x · Cited by 128
Zhu, Z., Sun, Z. J., Ye, Y., Voigt, J. H., Strickland, C., Smith, E. M., Cumming, J. N., Wang, L., Wong, J. K. Y., Wang, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901408p · Cited by 128
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors
Prati, F., De Simone, A., Bisignano, P., Armirotti, A., Summa, M., Pizzirani, D., Scarpelli, R., Perez, D. I., Andrisano, V., Perez‐Castillo, A., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201410456 · Cited by 128
The wobbler mouse, an ALS animal model
Moser, J., Bigini, P., & Schmitt‐John, T. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0741-0 · Cited by 128
Elimination of GD3 synthase improves memory and reduces amyloid-β plaque load in transgenic mice
Bernardo, A., Harrison, F. E., McCord, M., Zhao, J., Bruchey, A., Davies, S. S., Jackson Roberts, L., Mathews, P. M., Matsuoka, Y., Ariga, T., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.12.022 · Cited by 127
How superoxide radical damages the cell
Benov, L. (2001) · PROTOPLASMA · doi:10.1007/bf01289410 · Cited by 127
Bunina bodies in amyotrophic lateral sclerosis immunostained with rabbit anti-cystatin C serum
Okamoto, K., Hirai, S., Amari, M., Watanabe, M., & Sakurai, A. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90576-7 · Cited by 127
Ordentlich, A., Barak, D., Kronman, C., Ariel, N., Segall, Y., Velan, B., & Avigdor Shafferman, C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2082 · Cited by 126
α-Synuclein expression is modulated at the translational level by iron
Febbraro, F., Giorgi, M., Caldarola, S., Loreni, F., & Romero‐Ramos, M. (2012) · Neuroreport · doi:10.1097/wnr.0b013e328354a1f0 · Cited by 125
Neuroprotective effect of genistein against beta amyloid-induced neurotoxicity
Bang, O. Y., Hong, H., Kim, D. H., Kim, H., Boo, J. H., Huh, K., & Mook‐Jung, I. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.017 · Cited by 125
Wang, X., Lee, S. Y., Simmons, Z., Boyer, P. J., Scott, K. R., Liu, W., & Connor, J. R. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.08.003 · Cited by 125
Cu(II) Mediates Kinetically Distinct, Non-amyloidogenic Aggregation of Amyloid-β Peptides
Pedersen, J. T., Østergaard, J., Rozlosnik, N., Gammelgaard, B., & Heegaard, N. H. H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220863 · Cited by 125
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 124
Sequestration of Copper from β-Amyloid Promotes Selective Lysis by Cyclen-Hybrid Cleavage Agents
Wu, W., Lei, P., Liu, Q. R., Hu, J., Gunn, A. P., Chen, M., Rui, Y., Su, X., Xie, Z., Zhao, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804722200 · Cited by 124
Facteurs environnementaux dans l'étiologie de la maladie de Parkinson
Zayed, J., Ducic, S., Campanella, G., Panisset, J.-C., André, P., Masson, H., & Roy, M. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030584 · Cited by 124
Differential modulation by zinc and copper of amino acid receptors from rat olfactory bulb neurons
Trombley, P. Q., & Shepherd, G. M. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.4.2536 · Cited by 124
Evidence for two distinct binding sites for tau on microtubules
Makrides, V., Massie, M. R., Feinstein, S. C., & Lew, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400992101 · Cited by 123
Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
Abelein, A., Gräslund, A., & Danielsson, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421961112 · Cited by 123
Lu, Y., Prudent, M., Fauvet, B., Lashuel, H. A., & Girault, H. H. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200074d · Cited by 122
Nadal, R. C., Rigby, S. E. J., & Viles, J. H. (2008) · Biochemistry · doi:10.1021/bi8011093 · Cited by 122
Townsend, K. P., Town, T., Mori, T., Lue, L., Shytle, D., Sanberg, P. R., Morgan, D., Fernandez, F., Flavell, R. A., & Tan, J. (2005) · European Journal of Immunology · doi:10.1002/eji.200425585 · Cited by 121
Bhowmik, M., Khanam, R., & Vohora, D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02093.x · Cited by 121
Metal-catalyzed Oxidation of α-Synuclein
Cole, N. B., Murphy, D. D., Lebowitz, J., Noto, L. D., Levine, R. L., & Nussbaum, R. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409946200 · Cited by 120
Oxidized quercetin inhibits α-synuclein fibrillization
Zhu, M., Han, S., & Fink, A. L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.12.027 · Cited by 120
Comparative Studies of Huperzine A, E2020, and Tacrine on Behavior and Cholinesterase Activities
Cheng, D., & Tang, X. C. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00601-1 · Cited by 120
Chen, W.-T., Hong, C., Lin, Y.-T., Chang, W.-H., Huang, H.-T., Liao, J., Chang, Y.-J., Hsieh, Y.-F., Cheng, C.-Y., Liu, H.-C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035807 · Cited by 120
Biomarkers of oxidative and nitro‐oxidative stress: conventional and novel approaches
Gašparović, A. Č., Žarković, N., Žarković, K., Semen, K. O., Kaminskyy, D. V., Yelisyeyeva, O. P., & Bottari, S. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13673 · Cited by 120
Peng, Y., Wang, C., Xu, H. H., Liu, Y., & Zhou, F. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.11.005 · Cited by 119
Anderson, D. G., Mariappan, S. V. S., Buettner, G. R., & Doorn, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.249532 · Cited by 119
Lorenzen, N., Lemminger, L., Pedersen, J. N., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.12.015 · Cited by 118
Gong, Q., Wang, Q., Pan, L., Liu, X., Xin, H., & Zhu, Y. Z. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.09.001 · Cited by 118
Sangwan, S., Zhao, A., Adams, K. L., Jayson, C. K., Sawaya, M. R., Guenther, E. L., Pan, A. C., Ngo, J., Moore, D. M., Soriaga, A. B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705091114 · Cited by 118
Fibril fragmentation in amyloid assembly and cytotoxicity: When size matters
Xue, W.-F., Hellewell, A. L., Hewitt, E. W., & Radford, S. E. (2010) · Prion · doi:10.4161/pri.4.1.11378 · Cited by 117
Old and new acetylcholinesterase inhibitors for Alzheimer’s disease
Galimberti, D., & Scarpini, E. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1216972 · Cited by 117
Quantification of the Binding Constant of Copper(II) to the Amyloid-Beta Peptide
Hatcher, L. Q., Hong, L., Bush, W. D., Carducci, T. M., & Simon, J. D. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp710806s · Cited by 117
Koob, A. O., Ubhi, K. K., Paulsson, J. F., Kelly, J. W., Rockenstein, E. M., Mante, M., Adame, A., & Masliah, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.11.015 · Cited by 117
Morawski, M., Schilling, S., Kreuzberger, M., Waniek, A., Jäger, C., Koch, B. M., Cynis, H., Kehlen, A., Arendt, T., Hartlage‐Rübsamen, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131535 · Cited by 116
Ligand-Dependent Inhibition and Reversal of Tau Filament Formation
Chirita, C. N., Necula, M., & Kuret, J. (2004) · Biochemistry · doi:10.1021/bi036094h · Cited by 116
Artificial Membrane Assays to Assess Permeability
Faller, B. (2008) · Current Drug Metabolism · doi:10.2174/138920008786485227 · Cited by 116
Wang, Y., Strickland, C., Voigt, J. H., Kennedy, M. E., Beyer, B. M., Senior, M. M., Smith, E. M., Nechuta, T. L., Madison, V., Czarniecki, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901472u · Cited by 116
Hamuľaková, S., Janovec, L., Hrabinová, M., Špilovská, K., Korábečný, J., Kristián, P., Kuča, K., & Imrich, J. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008648 · Cited by 116
Nkhili, E., Loonis, M., Mihai, S., Hajji, H. E., & Dangles, O. (2014) · Food & Function · doi:10.1039/c4fo00007b · Cited by 115
Brotherton, T. E., Li, Y., Cooper, D., Gearing, M., Julien, J., Rothstein, J. D., Boylan, K., & Glass, J. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115009109 · Cited by 114
Jiang, N., Huang, Q., Liu, J., Liang, N., Li, Q., Li, Q., & Xie, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.055 · Cited by 114
Qiang, X., Sang, Z., Yuan, W., Li, Y., Liu, Q., Bai, P., Shi, Y., Ang, W., Tan, Z., & Deng, Y. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.045 · Cited by 113
Lamberto, G. R., Binolfi, A., Orcellet, M. L., Bertoncini, C. W., Zweckstetter, M., Griesinger, C., & Fernández, C. O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902603106 · Cited by 113
Benchekroun, M., Romero, A., Egea, J., Leon, R. M., Michalska, P., Buendía, I., Jimeno, M. L., Jun, D., Janočková, J., Šepsová, V., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01178 · Cited by 113
Miranda, H. V., Cássio, R., Guedes, L. C., Gomes, M. A., Chegão, A., Miranda, E., Soares, T., Coelho, M. M., Rosa, M. M., Ferreira, J. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14175-5 · Cited by 113
A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor
Shaltiel‐Karyo, R., Frenkel‐Pinter, M., Rockenstein, E. M., Patrick, C., Levy‐Sakin, M., Schiller, A., Egoz-Matia, N., Masliah, E., Segal, D., & Gazit, E. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.434787 · Cited by 112
Werner coordination chemistry and neurodegeneration
Telpoukhovskaia, M. A., & Orvig, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35236b · Cited by 112
Combating Alzheimer's Disease With Multifunctional Molecules Designed for Metal Passivation
Schugar, H. J., Green, D. E., Bowen, M. L., Scott, L. E., Storr, T., Böhmerle, K., Thomas, F. C., Allen, D. D., Lockman, P. R., Merkel, M., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603866 · Cited by 112
Talmard, C., Bouzan, A., & Faller, P. (2007) · Biochemistry · doi:10.1021/bi701355j · Cited by 111
Mayes, J., Tinker, C. L., Kolosov, O., Zhang, H., Tabner, B. J., & Allsop, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525212 · Cited by 111
Dikalov, S., Vitek, M. P., & Mason, R. P. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.004 · Cited by 110
Li, S., Wang, X., & Kong, L. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.068 · Cited by 110
A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation
McKoy, A. F., Chen, J., Schüpbach, T., & Hecht, M. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.348037 · Cited by 109
The binding of resveratrol to monomer and fibril amyloid beta
Ge, J., Qiao, J., Qi, C., Wang, C.-W., & Zhou, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.012 · Cited by 109
Kang, K. S., Wen, Y., Yamabe, N., Fukui, M., Bishop, S., & Zhu, B. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011951 · Cited by 109
Faller, P., & Hureau, C. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202697 · Cited by 109
Aliès, B., Conte‐Daban, A., Sayen, S., Collin, F., Kieffer, I., Guillon, E., Faller, P., & Hureau, C. (2016) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.6b01733 · Cited by 109
Schöneich, C., & Williams, T. D. (2002) · Chemical Research in Toxicology · doi:10.1021/tx025504k · Cited by 108
Recent Advances in the Treatment of Neurodegenerative Diseases Based on GSH Delivery Systems
Cacciatore, I., Baldassarre, L., Fornasari, E., Mollica, A., & Pinnen, F. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/240146 · Cited by 108
Buchholz, M., Heiser, U. F., Schilling, S., Niestroj, A. J., Zunkel, K., & Demuth, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050756e · Cited by 107
Mutations in FLVCR1 Cause Posterior Column Ataxia and Retinitis Pigmentosa
Rajadhyaksha, A. M., Elemento, O., Puffenberger, E. G., Schierberl, K. C., Xiang, J., Putorti, M. L., Berciano, J., Poulin, C., Brais, B., Michaelides, M., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.10.013 · Cited by 107
Zheng, H., Youdim, M. B. H., & Fridkin, M. (2010) · ACS Chemical Biology · doi:10.1021/cb900264w · Cited by 106
Kozikowski, A. P., Campiani, G., Sun, L., et al. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9622822 · Cited by 106
Butyrylcholinesterase and the cholinergic system
Reid, G. A., Chilukuri, N., & Darvesh, S. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.054 · Cited by 105
Jawhar, S., Wirths, O., Schilling, S., Graubner, S., Demuth, H., & Bayer, T. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.185819 · Cited by 105
Role of Aspartate-1 in Cu(II) Binding to the Amyloid-β Peptide of Alzheimer's Disease
Karr, J. W., & Szalai, V. A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068952d · Cited by 105
Cholesterol and metal ions in Alzheimer's disease
Lee, H. J., Korshavn, K. J., Kochi, A., Derrick, J. S., & Lim, M. H. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00005f · Cited by 105
Self-citationRichter, J. A., Perry, E. K., & Tomlinson, B. E. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90176-9 · Cited by 105
Pi, R., Mao, X., Chao, X., Cheng, Z., Liu, M., Duan, X., Ye, M., Chen, X., Mei, Z., Liu, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031921 · Cited by 105
Neural immunity: Friend or foe?
Gendelman, H. (2002) · Journal of Neurovirology · doi:10.1080/13550280290168631 · Cited by 105
Wu, M., Esteban, G., Brogi, S., Shionoya, M., Wang, L., Campiani, G., Unzeta, M., Inokuchi, T., Butini, S., & Marco‐Contelles, J. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.10.001 · Cited by 104
Manganese Superoxide Dismutase Protects against 6-Hydroxydopamine Injury in Mouse Brains
Callio, J., Oury, T. D., & Chu, C. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413224200 · Cited by 104
Soto-Ortega, D. D., Murphy, B. P., Gonzalez‐Velasquez, F. J., Wilson, K. A., Xie, F., Wang, Q., & Moss, M. A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.010 · Cited by 104
Crowe, A., Huang, W., Ballatore, C., Johnson, R. L., Hogan, A. L., Huang, R., Wichterman, J., McCoy, J. G., Huryn, D. M., Auld, D. S., et al. (2009) · Biochemistry · doi:10.1021/bi9006435 · Cited by 104
Trapaidze, A., Hureau, C., Bal, W., Winterhalter, M., & Faller, P. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0824-5 · Cited by 103
Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS
Goodall, G., Greenway, M. J., van Marion, I., Carroll, C., Hardiman, O. M., & Morrison, K. E. (2005) · Neurology · doi:10.1212/01.wnl.0000176032.94434.d4 · Cited by 103
From Resveratrol to Its Derivatives: New Sources of Natural Antioxidant
He, S., & Yan, X. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713805288941 · Cited by 103
Lhermitte, J., Kraus, W. M., & McAlpine, D. (1924) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-5.19.195 · Cited by 103
Chao, X., He, X., Yang, Y., Zhou, X., Jin, M., Liu, S., Cheng, Z., Liu, P., Wang, Y., Yu, J., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.036 · Cited by 103
Aliès, B., Badei, B., Faller, P., & Hureau, C. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102746 · Cited by 103
Sang, Z., Pan, W., Wang, K., Ma, Q., Yu, L., Yang, Y. G., Bai, P., Leng, C., Xu, Q., Li, X., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.02.039 · Cited by 103
Effects of Clioquinol on Metal-Triggered Amyloid-β Aggregation Revisited
Mancino, A. M., Hindo, S. S., Kochi, A., & Lim, M. H. (2009) · Inorganic Chemistry · doi:10.1021/ic9014256 · Cited by 102
Self-citationIn vitro aggregation assays for the characterization of α-synuclein prion-like properties
Narkiewicz, J., Giachin, G., & Legname, G. (2014) · Prion · doi:10.4161/pri.28125 · Cited by 102
Gaggelli, E., Janicka-Kłos, A., Jankowska, E., Kozłowski, H., Migliorini, C., Molteni, E., Valensin, D., Valensin, G., & Wieczerzak, E. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp075168m · Cited by 102
Neuroprotection in Parkinson's disease: Clinical trials
Stocchi, F., & Olanow, C. W. (2003) · Annals of Neurology · doi:10.1002/ana.10488 · Cited by 102
Molecular Basis for Preventing α-Synuclein Aggregation by a Molecular Tweezer
Acharya, S., Safaie, B. M., Wongkongkathep, P., Ivanova, M. I., Attar, A., Klärner, F. G., Schrader, T. H., Loo, J. A., Bitan, G., & Lapidus, L. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524520 · Cited by 101
Fonseca‐Ornelas, L., Eisbach, S. E., Paulat, M., Giller, K., Fernández, C. O., Outeiro, T. F., Becker, S., & Zweckstetter, M. (2014) · Nature Communications · doi:10.1038/ncomms6857 · Cited by 101
Gomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 101
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s disease
Bai, R., Guo, J., Ye, X.-Y., Xie, Y., & Xie, T. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101619 · Cited by 813
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201901778 · Cited by 601
Energy metabolism in health and diseases
Liu, H., Wang, S., Wang, J., Guo, X., Song, Y., Fu, K., Gao, Z., Liu, D., He, W., & Yang, L.-L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02141-x · Cited by 399
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Tam, K., & Ju, Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.320970 · Cited by 395
Metadata
- Authors
- Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-08-10
- Volume
- 119
- Issue
- 2
- Pages
- 1221-1322
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2886819196
- Cited by
- 581
- References
- 1,155
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.